[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335422-105":59,"doc-detail-335422-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","overexpression-of-glyoxalase-2-in-human-breast-cancer-cells-implications-for-cell-proliferation-and-doxorubicin-resistance","Overexpression of Glyoxalase 2 in Human Breast Cancer Cells: Implications for Cell Proliferation and Doxorubicin Resistance","","Glyoxalase 2 (Glo2) is an enzyme in the glyoxalase system that removes methylglyoxal (MGO) in a pathway linked to glycolysis. This study evaluated additional nuclear roles of Glo2 in breast cancer (MCF7) and non-cancer (HDF) cell lines, focusing on proliferation and chemotherapy resistance. Glo2 was overexpressed in cancer cells, highest during S and G2/M phases, and enhanced S-glutathionylation in both cytoplasm and nucleus. Inhibiting Glo2 increased doxorubicin sensitivity, suggesting a therapeutic targeting strategy via oxidative stress regulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/overexpression-of-glyoxalase-2-in-human-breast-cancer-cells-implications-for-cell-proliferation-and-doxorubicin-resistance/335422/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/overexpression-of-glyoxalase-2-in-human-breast-cancer-cells-implications-for-cell-proliferation-and-doxorubicin-resistance/335422.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is Glyoxalase 2 (Glo2) and why is it relevant to cancer cells?","Question",{"text":112,"@type":113},"Glo2 is part of the glyoxalase system that detoxifies methylglyoxal (MGO). The study notes that both Glo1 and Glo2 are generally overexpressed in cancer cells due to elevated metabolic activity and MGO accumulation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does Glo2 expression relate to the cell cycle and proliferation in breast cancer cells?",{"text":117,"@type":113},"Glo2 expression is higher during proliferative phases of the cell cycle, specifically S and G2/M, in the cancer cells studied.",{"name":119,"@type":110,"acceptedAnswer":120},"How does inhibiting Glo2 affect doxorubicin sensitivity?",{"text":121,"@type":113},"Using p-NCBG to inhibit Glo2 increased the sensitivity of cancer cells to doxorubicin, indicating that Glo2 contributes to chemotherapy resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335422,1790017044,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nOverexpression of Glyoxalase 2 in Human Breast Cancer Cells: Implications for Cell Proliferation and Doxorubicin Resistance  \nBrenda Romaldi 1,†, Andrea Scirè 2,†, Cristina Minnelli 2, Andrea Frontini 2, Giulia Casari 1,  \nLaura Cianfruglia 1, Giovanna Mobbili 2, Lidia de Bari 3, Cinzia Antognelli 4, Federico V. Pallardó 5 and Tatiana Armeni 1, *  \nCitation: Romaldi, B.; Scirè, A.; Minnelli, C.; Frontini, A.; Casari, G.; Cianfruglia, L.; Mobbili, G.; de Bari, L.; Antognelli, C.; Pallardó, F.V.; et al. Overexpression of Glyoxalase 2 in Human Breast Cancer Cells:  \nImplications for Cell Proliferation and Doxorubicin Resistance. Int. J. Mol. Sci. 2024, 25, 10888. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms252010888](10.3390/ijms252010888)  \nAcademic Editor: Josiah Ochieng  \nReceived: 18 July 2024  \nRevised: 2 October 2024  \nAccepted: 7 October 2024  \nPublished: 10 October 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Odontostomatologic and Specialized Clinical Sciences, Università Politecnica delle Marche, 60131 Ancona, Italy; [b.romaldi@pm.univpm.it](b.romaldi@pm.univpm.it) (B.R.); [g.casari@staff.univpm.it](g.casari@staff.univpm.it) (G.C.); [lauretta2086@gmail.com](lauretta2086@gmail.com) (L.C.)  \n2 Department of Life and Environmental Sciences, Università Politecnica delle Marche, 60131 Ancona, Italy; [a.a.scire@staff.univpm.it](a.a.scire@staff.univpm.it) (A.S.); [c.minnelli@staff.univpm.it](c.minnelli@staff.univpm.it) (C.M.); [a.frontini@staff.univpm.it](a.frontini@staff.univpm.it) (A.F.); [g.mobbili@staff.univpm.it](g.mobbili@staff.univpm.it) (G.M.)  \n3 Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), National Research Council (CNR), 70126 Bari, Italy; [l.debari@ibiom.cnr.it](l.debari@ibiom.cnr.it)  \n4 Department of Medicine and Surgery, Università degli Studi di Perugia, 06129 Perugia, Italy; [cinzia.antognelli@unipg.it](cinzia.antognelli@unipg.it)  \n5 Department of Physiology, Medicine and Dentistry School, University of Valencia-INCLIVA, Center for Biomedical Network Research on Rare Diseases (CIBERER), 46010 Valencia, Spain; [federico.v.pallardo@uv.es](federico.v.pallardo@uv.es)  \n* Correspondence: [t.armeni@staff.univpm.it](t.armeni@staff.univpm.it); Tel.: +39-071-2204376 † These authors contributed equally to the work.  \nAbstract: Glyoxalase 2 (Glo2) is an enzyme of the glyoxalase system whose pathway parallels glycolysis and which aims to remove methylglyoxal (MGO) . This study analyzed the possible additional roles of the Glo2 enzyme in breast cancer (MCF7) and non-cancer (HDF) cell lines, investigating its presence at the nuclear level and its potential involvement in cell proliferation and chemotherapy resistance. The results revealed that Glo2 is overexpressed in cancer cells, and its expression is higher during the proliferative (S and G2/M) phases of the cell cycle. The study also examined a post-translational modification (PTM) in which Glo2 could be involved, with S-glutathionylation revealing that Glo2 enhances this PTM in cancer cells both in the cytoplasm and nucleus. Inhibition of Glo2 by p-NCBG resulted in increased sensitivity to doxorubicin, a common chemotherapeutic agent. This suggests that Glo2 increases cancer cell resistance to chemotherapy, potentially through its role in regulating oxidative stress. These results highlight Glo2 as a potential therapeutic target to improve the efficacy of existing treatments.  \nKeywords: glyoxalase 2 (Glo2); breast cancer cells; nucleus; proliferation; S-glutathionylation; redox metabolism  \n1. Introduction  \nThe glyoxalase system is an important glutathione (GSH)-de","cbCaigi5wV7WdC9e","https://ap.wps.com/l/cbCaigi5wV7WdC9e","pdf",5369397,"English","# Abstract\n# Introduction","[{\"question\":\"What is Glyoxalase 2 (Glo2) and why is it relevant to cancer cells?\",\"answer\":\"Glo2 is part of the glyoxalase system that detoxifies methylglyoxal (MGO). The study notes that both Glo1 and Glo2 are generally overexpressed in cancer cells due to elevated metabolic activity and MGO accumulation.\"},{\"question\":\"How does Glo2 expression relate to the cell cycle and proliferation in breast cancer cells?\",\"answer\":\"Glo2 expression is higher during proliferative phases of the cell cycle, specifically S and G2/M, in the cancer cells studied.\"},{\"question\":\"How does inhibiting Glo2 affect doxorubicin sensitivity?\",\"answer\":\"Using p-NCBG to inhibit Glo2 increased the sensitivity of cancer cells to doxorubicin, indicating that Glo2 contributes to chemotherapy resistance.\"}]","Overexpression of Glyoxalase 2 in Human Breast Cancer Cells: Implications for Cell Proliferation and Doxorubicin Resistance | PDF",1790010944,48]